Metabolism News and Research

Latest Metabolism News and Research

Taking a break in the middle of your workout may metabolize more fat

Taking a break in the middle of your workout may metabolize more fat than exercising without stopping, according to a recent study in Japan.

19 Jul 2007

New approach for restless legs syndrome

Scientists at deCODE genetics ( NASDAQ:DCGN ) in collaboration with colleagues from Emory University today report the discovery of the first variant in the sequence of the human genome ever linked to risk of Restless Legs Syndrome (RLS) and Periodic Limb Movements (PLMs).

19 Jul 2007

Potential dangers of Ritalin

Use of the attention deficit/hyperactivity disorder (ADHD) drug Ritalin by young children may cause long-term changes in the developing brain, suggests a new study of very young rats by a research team at Weill Cornell Medical College in New York City.

18 Jul 2007

New method for early disease diagnosis

Purdue University researchers worked with the Indiana University School of Medicine to establish a technique that provides a new approach for detecting a number of genetic disorders found in infants and young children.

18 Jul 2007

Suicide gene therapy for cancer

Cutting-edge research at South Dakota State University may yield a new therapy that targets only cancer cells, leaving healthy cells unharmed.

18 Jul 2007

Nastech Pharmaceutical Co. issued patents for parathyroid hormone nasal spray for treatment of osteoporosis

Nastech Pharmaceutical Company Inc. has announced the issuance of two U.S. patents by the U.S. Patent and Trademark Office.

18 Jul 2007

Grapefruit linked to increased risk for breast cancer

It seems unlikely but researchers in the United States say they have found that eating too much grapefruit could increase the risk of breast cancer.

17 Jul 2007

Warwick first new medical school to join MRC strategic partnership

Warwick Medical School has become the first new medical school to join a strategic partnership with the Medical Research Council (MRC).

16 Jul 2007

Curing canine cancer - human cancer benefit

One of the major issues associated with longer life expectancy in man and his best friend is an increase in the incidence of cancer.

13 Jul 2007

Turn back the clock and drink a pint of milk a day for health!

A pint of milk a day could be back in fashion again following the results of a new study which says dairy foods can protect against metabolic syndrome.

12 Jul 2007

New approach to predict protein function

In a paper published online this month in the journal Nature Chemical Biology, researchers report that they have developed a way to determine the function of some of the hundreds of thousands of proteins for which amino acid sequence data are available, but whose structure and function remain unknown.

12 Jul 2007

Ajinomoto to market Capsiate Natura in the U.S.

Ajinomoto has announced plans to introduce Capsiate Natura, a capsinoid dietary supplement, into the United States market.

12 Jul 2007

Diabetes researcher honored with prestigious Novartis prize

John E. Gerich, M.D., professor of Medicine and program director of the General Clinical Research Center at the University of Rochester Medical Center, has been awarded the Novartis Prize for Long-Standing Achievement in Diabetes.

11 Jul 2007

Master switch for the production of brown fat discovered

Researchers at Dana-Farber Cancer Institute have identified a long-sought "master switch" in mice for the production of brown fat, a type of adipose tissue that generates heat and counters obesity caused by overeating.

11 Jul 2007

Adiponectin serves as energy-conserving signal to the brain

A fat-derived protein known for its effects on the liver and skeletal muscle might also serve as an energy-conserving signal to the brain during periods of starvation, suggests a new study in the July issue of Cell Metabolism, a publication of Cell Press.

11 Jul 2007

Incretin-based therapy offers alternative option for treating type 2 diabetes

A review of previous studies indicates that use of a class of medications known as “incretin-based therapy”, which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.

11 Jul 2007